Insulet Corp

PODDNasdaqCIK 1145197HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 332 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Insulet Corp, Reports and events
Filed	Form	What it is	Accession number
2022-01-3117:41 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001145197-22-000003
2021-11-0517:59 ET	10-Q	Quarterly reportPeriod 2021-09-30	0001145197-21-000041
2021-11-0416:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001145197-21-000040
2021-10-1806:06 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001145197-21-000034
2021-10-0416:05 ET	8-K	8.01 Other events	0001145197-21-000032
2021-08-0618:04 ET	10-Q	Quarterly reportPeriod 2021-06-30	0001145197-21-000030
2021-08-0516:07 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001145197-21-000029
2021-06-1517:22 ET	8-K	3.02 Unregistered sale of equity	0001193125-21-191308
2021-06-0116:08 ET	8-K	5.07 Shareholder vote results	0001145197-21-000023
2021-05-1406:32 ET	8-K	3.02 Unregistered sale of equity	0001193125-21-161187
2021-05-0717:56 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001145197-21-000016
2021-05-0616:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001145197-21-000015
2021-05-0508:39 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001193125-21-150953
2021-04-2916:17 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-140464
2021-04-1908:02 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-21-120403
2021-04-1316:01 ET	DEF 14A	Proxy statementPeriod 2021-05-27	0001140361-21-012583
2021-02-2417:55 ET	10-K	Annual reportPeriod 2020-12-31	0001145197-21-000009
2021-02-2316:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001145197-21-000008
2021-02-1916:05 ET	8-K	5.02 Departure or appointment of officers or directors	0001145197-21-000002
2020-12-2816:02 ET	8-K	8.01 Other events	0001145197-20-000040
2020-11-0518:02 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001145197-20-000037
2020-11-0416:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001145197-20-000035
2020-10-2016:03 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001145197-20-000030
2020-08-0718:13 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001145197-20-000026
2020-08-0616:08 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001145197-20-000023
2020-06-0117:09 ET	8-K	5.07 Shareholder vote results	0001145197-20-000017
2020-05-1516:04 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001140361-20-011761
2020-05-1321:51 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001140361-20-011493
2020-05-1216:40 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001140361-20-011444
2020-05-0818:01 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001145197-20-000009
2020-05-0716:09 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-20-000706
2020-04-1316:02 ET	DEF 14A	Proxy statementPeriod 2020-05-29	0001140361-20-008712
2020-02-2619:39 ET	10-K	Annual reportPeriod 2019-12-31	0001145197-20-000004
2020-02-2516:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-20-000262
2019-11-0618:05 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001145197-19-000037
2019-11-0516:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-19-002191
2019-09-1617:29 ET	8-K	8.01 Other events	0001193125-19-245924
2019-09-0916:13 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits	0001193125-19-240972
2019-09-0406:09 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-19-236986
2019-09-0307:11 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-19-235798
2019-08-0617:57 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001145197-19-000033
2019-08-0516:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-19-001704
2019-07-3117:24 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001145197-19-000029
2019-05-3016:20 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001145197-19-000023
2019-05-0317:50 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001145197-19-000020
2019-05-0216:05 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001157523-19-001053
2019-04-3017:11 ET	8-K	5.02 Departure or appointment of officers or directors	0001145197-19-000016
2019-04-1208:03 ET	DEF 14A	Proxy statementPeriod 2019-05-30	0001145197-19-000010
2019-02-2821:45 ET	10-K/A	Annual report, amendedPeriod 2018-12-31	0001145197-19-000005
2019-02-2617:58 ET	10-K	Annual reportPeriod 2018-12-31	0001145197-19-000003

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.